Yifan Pharmaceutical Co., Ltd. (002019.SZ)
CNY 11.38
(0.53%)
CNY 11.38
(0.53%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 352.88 Million | 472.06 Million | 301.23 Million | 1.1 Billion | 937.24 Million | 1.17 Billion |
| Net Income | -551.07 Million | 127.15 Million | 242.21 Million | 931.39 Million | 873.11 Million | 693.67 Million |
| Depreciation & Amortization | 279.81 Million | 228.42 Million | 207.17 Million | 177.01 Million | 153.68 Million | 121.5 Million |
| Deferred income taxes | -52.71 Million | -53.93 Million | -87.02 Million | -33.43 Million | -44.48 Million | -4.6 Million |
| Stock-based compensation | - | - | -6.97 Million | 82.83 Million | 47.77 Million | - |
| Change in working capital | -34.96 Million | -168.18 Million | -285.42 Million | -178.5 Million | -275.13 Million | 226.22 Million |
| Other non-cash items | 1.32 Billion | 284.66 Million | 231.26 Million | 129.21 Million | 182.28 Million | 129.48 Million |
| Investing Cash Flow | -536.78 Million | -670.16 Million | -507.89 Million | -770.55 Million | -1.58 Billion | -616.52 Million |
| Investments in PPE | -504.08 Million | -542.27 Million | -571.73 Million | -715.7 Million | -866.07 Million | -729.21 Million |
| Acquisitions | 6.42 Million | 1.2 Million | -26.09 Million | -36.81 Million | -818.8 Million | -449.08 Million |
| Investment purchases | -1.48 Billion | -1.25 Billion | -1.26 Billion | -1.14 Billion | -922.93 Million | -825.5 Million |
| Sales/Maturities of investments | 1.44 Billion | 1.11 Billion | 1.33 Billion | 1.12 Billion | 1.02 Billion | 1.38 Billion |
| Other Investing Activities | -28.74 Million | 6.45 Million | 17.7 Million | 959.57 Thousand | 815.99 Thousand | 689.36 Thousand |
| Financing Cash Flow | 30.42 Million | -12.66 Million | 222.15 Million | -567.94 Million | 151.08 Million | -246.72 Million |
| Debt repayment | -168.09 Million | -1.88 Billion | -2.43 Billion | -2.21 Billion | -2.06 Billion | -1.82 Billion |
| Dividends payments | -72.46 Million | -1.2 Million | -61.67 Million | -123.42 Million | -120.69 Million | -543.45 Million |
| Common Stock Repurchased | -37.99 Million | -53.55 Million | -121.47 Million | -1.61 Million | - | - |
| Common Stock Issuance | - | 846.4 Thousand | 1 Million | 1.61 Million | - | - |
| Other Financing Activities | 257.8 Million | 2 Billion | 2.91 Billion | 1.84 Billion | 2.41 Billion | 2.11 Billion |
| Accounts receivables | -10.24 Million | -103.77 Million | -18.58 Million | -117.7 Million | -58.04 Million | 185.23 Million |
| Accounts payables | 62.88 Million | 156.62 Million | -99.33 Million | -49.21 Million | -59.1 Million | 52.54 Million |
| Inventory | -109.38 Million | -167.1 Million | -80.48 Million | 21.85 Million | -113.48 Million | -6.95 Million |
| Other working capital | 21.79 Million | -53.93 Million | -87.02 Million | -33.43 Million | -44.48 Million | 233.17 Million |
| Cash at beginning of period | 1.14 Billion | 862.82 Million | 868.18 Million | 1.09 Billion | 1.58 Billion | 1.28 Billion |
| Cash at end of period | 698.36 Million | 711.62 Million | 862.82 Million | 868.18 Million | 1.09 Billion | 1.58 Billion |
| Capital Expenditure | -504.08 Million | -542.27 Million | -571.73 Million | -715.7 Million | -866.07 Million | -729.21 Million |
| Effect of forex changes on cash | 14.59 Million | 59.56 Million | -20.85 Million | 1.33 Million | 9.57 Million | -2.95 Million |
| Net cash flow / Change in cash | -445.41 Million | -151.2 Million | -5.35 Million | -228.66 Million | -488.54 Million | 304.69 Million |
| Free Cash Flow | -151.2 Million | -70.2 Million | -270.5 Million | 392.79 Million | 71.16 Million | 441.68 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 113.15 Million | 107.12 Million | 146.09 Million | -697.91 Million | -551.07 Million | 38.18 Million |
| Depreciation & Amortization | - | 86.93 Million | 86.93 Million | 76.19 Million | 279.81 Million | -121.2 Million |
| Deferred income taxes | - | - | - | - | -52.71 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -594.18 Million | - | -97.84 Million | -34.96 Million | 151.85 Million |
| Other non-cash items | 96.76 Million | -56.62 Million | 34.86 Million | 778.28 Million | 1.32 Billion | 35.17 Million |
| Investing Cash Flow | -173.51 Million | -118.82 Million | -76.39 Million | -505.87 Million | -536.78 Million | -18.27 Million |
| Investments in PPE | -128.7 Million | -124.73 Million | -131.76 Million | -133.73 Million | -504.08 Million | -114.38 Million |
| Acquisitions | -95.26 Thousand | 1.2 Million | 5.37 Million | 2.98 Million | 6.42 Million | 195.06 Thousand |
| Investment purchases | -359.72 Million | -91.15 Million | -15 Million | -697.4 Million | -1.48 Billion | -225 Million |
| Sales/Maturities of investments | 315.01 Million | 95.86 Million | 65 Million | 322.27 Million | 1.44 Billion | 320.91 Million |
| Other Investing Activities | - | 5.54 Million | 55.49 Million | -404.55 Million | -28.74 Million | 1.02 |
| Financing Cash Flow | 136.84 Million | 192.92 Million | 13.86 Million | 335.17 Million | 30.42 Million | -211.14 Million |
| Debt repayment | -293.97 Million | -185.13 Million | -43.55 Million | -57.61 Million | -168.09 Million | -397.23 Million |
| Dividends payments | - | -16.85 Million | -15.79 Million | -16.88 Million | -72.46 Million | -9.25 Million |
| Common Stock Repurchased | - | - | - | -37.99 Million | -37.99 Million | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -157.12 Million | 16.43 Million | -29.68 Million | 336.83 Million | 257.8 Million | 195.33 Million |
| Accounts receivables | - | -444.39 Million | - | -10.24 Million | -10.24 Million | -9.51 Million |
| Accounts payables | - | - | - | - | 62.88 Million | -714.85 Thousand |
| Inventory | - | -148.13 Million | - | -109.38 Million | -109.38 Million | 161.37 Million |
| Other working capital | - | -1.66 Million | - | 21.79 Million | 21.79 Million | 714.85 Thousand |
| Cash at beginning of period | 764.48 Million | 810.55 Million | 698.36 Million | 744.39 Million | 1.14 Billion | 812.83 Million |
| Cash at end of period | 1.01 Billion | 764.48 Million | 810.55 Million | 698.36 Million | 698.36 Million | 682.98 Million |
| Capital Expenditure | -128.7 Million | -124.73 Million | -131.76 Million | -133.73 Million | -504.08 Million | -114.38 Million |
| Effect of forex changes on cash | - | 1.44 Million | -2.34 Million | 1.75 Million | 14.59 Million | -4.45 Million |
| Net cash flow / Change in cash | 253.37 Million | -46.07 Million | 112.18 Million | -46.02 Million | -445.41 Million | -129.85 Million |
| Free Cash Flow | 81.21 Million | -161.17 Million | 49.19 Million | -75.01 Million | -151.2 Million | -10.36 Million |
DSV
MNDY
PKP
603963
SHRICON
ORGN